Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 8Recruiting 4Terminated 3Active not recruiting 3Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Neoplasms 2Uterine Neoplasms 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Adenosquamous 1Adenocarcinoma 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Hysterectomy × Clear all
NCT06752135 2024-12-30

HRCC1

Azienda Policlinico Umberto I

Terminated
97 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
3 enrolled
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT01363466 2011-06-01

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

UNICANCER

Phase 3 Terminated
61 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡